Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth

Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth

Becton, Dickinson and Company reported strong fourth-quarter sales, exceeding expectations. The company is focusing on higher-growth areas and innovation to enhance patient care. BD projects growth and increased dividends for FY25 despite challenges in China and the Pharma market.

Read More

Did you find this insightful?